Skip to main content
. 2020 Mar 26;10(4):32. doi: 10.3390/life10040032

Figure 3.

Figure 3

(AC) Survey respondents who agreed that genetic testing of HTN patients provides information that may change which antihypertensives are prescribed (Q20) were more likely to agree that (A) genetic testing will help diagnose the cause of a patient’s CKD more effectively (Q2, p = 0.00004), and (B) nephrologists should be trained in genetic testing interpretation and patient counseling (Q12, p = 0.0040). However, those who agreed with question 20 were split halfway on whether they agreed or disagreed that (C) they feel comfortable discussing genetic test results with patients (Q16, p = 0.0194). Response colors are strongly agree (white), agree (light gray), neutral (medium gray), disagree (dark gray), and strongly disagree (black).